Leishmanicidal activities of the extract from Blepharocalyx salicifolius (Kunth) O. Berg, Myrtaceae;Atividade leishmanicida do extrato de Blepharocalyx salicifolius (Kunth) O. Berg, Myrtaceae

Revista Brasileira de Farmacognosia

Volumn 20, Issue 3, 2010, Pages 416-421

  de Siqueira, Ezequias Pessoa ^a   de Souza Fagundes, Elaine Maria ^b   Sobral, Marcos Eduardo Guerra ^b   de Almeida Alves, Tânia Maria ^a   Rabello, Ana ^a   Zani, Carlos Leomar ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Blepharocalyx salicifolius; Citotoxicity; Gel permeation chromatography; Leishmania (leishmania) amazonensis; Myrtaceae

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; BLEPHAROCALYX SALICIFOLIUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIPARASITIC ACTIVITY; ARTICLE; BLEPHAROCALYX SALICIFOLIUS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG ISOLATION; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEISHMANIA; MYRTACEAE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLANT LEAF;

EID: 77957577067     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0102-695x2010000300020     Document Type: Article

References (24)

1. Ayres DC, Marcucci MC, Giorgio S 2007. Effects of brazilian propolis on Leishmania amazonensis. Mem Inst Oswaldo Cruz 102: 215-220.
2. Balunas MJ, Jones WP, Chin YW, Mi Q, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, Pezzuto JM, Chai HB, Kinghorn AD 2006. Relationships between inhibitory activity against a cancer cell line panel, profiles of plants collected, and compound classes isolated in an anticancer drug discovery project. Chem Biodiv 3: 897-915.
3. Braga FG, Bouzada MLM, Fabri RL, Matos MD, Moreira FO, Scio E, Coimbra ES 2007. Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J Ethnopharmacol 111: 396-402.
4. Brenzan MA, Nakamura CV, Dias BP, Ueda NT, Young MCM, Cortez DAG 2007. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res 101: 715-722.
5. Carfi M, Gennari A, Malerba I, Corsini E, Pallardy M, Pieters R, Van Loveren H, Vohr HW, Hartung T, Gribaldo L 2007. In vitro tests to immunotoxicity: A preliminary study. Toxicology 229: 11-22.
6. Dube A, Singh N, Saxena A, Lakshmi V 2007. Antileishmanial potential of a marine sponge, Haliclona exigua (Kirkpatrick) against experimental visceral leishmaniasis. Parasitol Res 101: 317-324.
7. Gazzinelli G, Katz N, Rocha RS, Colley DG 1983. Immune response during human schistosomiasis mansoni X. Production and standartization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated but not active cases of schistosomiasis. J Immunol 130: 2891-2895.
8. Jiang J, Xu Q 2003. Immunomodulatory activity of the aqueous extract from rhizome of Smilax glabra in the later phase of adjuvant-induced arthritis in rats. J Ethnopharmacol 85: 53-59.
9. Lima LA, Siani AC, Brito FA, Sampaio ALF, Henriques MGMO, Riehl CAS 2007. Correlation of anti-inflammatory activity with phenolic content in the leaves of Syzygium cumini (L.) Skeels (Myrtaceae). Quim Nova 30: 860-864.
10. Limberger RP, Sobral MEG, Zuanazzi JAS, Moreno PRH, Schapoval EES, Henriques AT 2001. Biological activities and essential oil composition of leaves of Blepharocalyx salicifolius. Pharm Biol 39: 308-311.
11. Marzouk MSA, Moharram FA, Mohamed MA, Gamal-Eldeen AM, Aboutabl EA 2007. Anticancer and antioxidant tannins from Pimenta dioica leaves. J Bioscience 62: 526-536.
12. Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi BB, Costa SS 2006. Assessment of antileishmanial activity of new and unusual flavonoids from Kalanchoe pinnata. Phytochemistry 67: 2071-2077.
13. Narayan S, Bimal S, Singh SK, Grupta AK, Singh VP, Sinha PK, Das P 2009. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Exp Parasitol 121: 69-75.
14. Pecoul B, Chirac P, Trouiller P, Pinel J 1999. Access to essential drugs in poor countries-A lost battle? Jama-J Am Med Assoc 281: 361-367.
15. Rao KV, Kasanah N, Wahyuono SU, Tekwani BL, Schinazi RF, Hamann MT 2004. Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. J Nat Prod 67: 1314-1318.
16. Rocha LG, Almeida J, Macedo RO, Barbosa-Filho JM 2005. A review of natural products with antileishmanial activity. Phytomedicine 12: 514-535.
17. Schmidt JM, Noletto JA, Vogler B, Setzer WN 2006. Abaco Bush medicine: chemical composition of the essential oils of four aromatic medicinal plants from Abaco Island, Bahamas. J Herbs Spices Med Plants 12: 43-65.
18. Soares DC, Pereira CG, Meireles MAA, Saraiva EM 2007. Leishmanicidal activity of a supercritical fluid fraction obtained from Tabernaemontana catharinensis. Parasitol Int 56: 135-139.
19. Soto J, Toledo J, Gutierrez P, Nicholls RS, Padilla J, Engel J, Fischer C, Voss A, Berman J 2001. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 33: 57-61.
20. Teixeira MCA, Santos RJ, Sampaio RB, Carvalho LP, Santos WLC 2002. A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species. Parasitol Res 88: 963-968.
21. Werka JS, Boehme AK, Setzer WN 2007. Biological activities of essential oils from Monteverde, Costa Rica. Nat Prod Commun 2: 1215-1219.
22. Wilson PG, O'Brien MM, Gadek PA, Quinn CJ 2001. Myrtaceae revisited: A reassessment of infrafamilia groups1. Am J Bot 88: 2013-2025.
23. Woollard JMR, Perry NB, Weavers RT, Klink JW 2008. Bullatenone, 1,3-dione and sesquiterpene chemotypes of Lophomyrtus species. Phytochemistry 69: 1313-1338.
24. WHO (World Healt Organization) 2003. Public health mapping group communicable diseases (CDS). http://www.who.int/leishmaniasis/leishmaniasis_maps/en/index.html, access at October 2003.